泰凌医药(01011.HK)暂停买卖 以待刊发内幕消息

Core Viewpoint - 泰凌医药 announced a suspension of trading for its shares on the Hong Kong Stock Exchange due to the pending release of an announcement containing insider information [1] Group 1 - The trading suspension will take effect on August 19, 2025, at 1:00 PM [1] - The suspension is requested by the company itself [1] - The announcement is expected to contain significant insider information relevant to the company [1]